Evidence map›Paper›PMID 28623398›Full record

ArticleHeart and vessels2017

Endothelial vascular markers in coronary surgery.

Diana M Valencia-Nuñez, Willy Kreutler, Javier Moya-Gonzalez, Pedro Alados-Arboledas, Ignacio Muñoz-Carvajal, Andrés Carmona, Rafael Ramirez-Chamond, Julia Carracedo-Añon

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Diana M Valencia-NuñezDepartment of Cardiovascular Surgery, Hospital Universitario Reina Sofía, Córdoba, Spain. dianavalenciaes@yahoo.es.
Willy KreutlerDEKRA, Chemnitz, Germany.
Javier Moya-GonzalezDepartment of Cardiovascular Surgery, Hospital Universitario Reina Sofía, Córdoba, Spain.
Pedro Alados-ArboledasDepartment of Cardiovascular Surgery, Hospital Universitario Reina Sofía, Córdoba, Spain.
Ignacio Muñoz-CarvajalDepartment of Cardiovascular Surgery, Hospital Universitario Reina Sofía, Córdoba, Spain.
Andrés CarmonaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain.
Rafael Ramirez-ChamondBiología de Sistemas Department, Alcalá de Henares University, Madrid, Spain.
Julia Carracedo-AñonFisiología Animal II Department, Universidad Complutense de Madrid. Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Hospital Universitario Reina Sofía · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESResearch Institute Hospital 12 de Octubre · ESUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary heart disease is associated with high morbidity and mortality. Endothelial dysfunction in affected patients is linked to long-term atherosclerotic disease progression and cardiovascular event rates. The present paper reports on changes in the levels of endothelial progenitor cells (VEGFR2/CD133/CD34), essential for endothelial repair, and of endothelial microvesicles (CD31/annexin V) as indicators of endothelial lesion, in patients undergoing coronary bypass surgery with respect both to baseline levels and to counts in healthy subjects. In an observational descriptive study, 31 patients scheduled for coronary revascularization surgery were compared with those of 25 healthy controls. In a subsequent longitudinal study, patients undergoing surgery were monitored at 5 timepoints up until 48 h after surgery. Endothelial progenitor cell (VEGFR2/CD133/CD34) and endothelial microvesicle (CD31/annexin V) levels were quantified by flow cytometry. Baseline endothelial progenitor cell counts in coronary patients were significantly lower than those of healthy controls (p < 0.001); however, after surgery, levels rose steadily over all 5 timepoints to 48 h  with statistically significant differences (p < 0.001) between intra-operative and 48 h after surgery (T5). Endothelial microvesicle levels were significantly higher in coronary patients prior to surgery than in healthy controls (p < 0.001), and despite declining at 48 h remained significantly higher than those of controls (p < 0.001). Coronary surgery has had a positive impact on the endothelium in the patients, prompting a decrease in signs of endothelial dysfunction and a considerable improvement in the endothelial repair mechanisms involved in angiogenesis, playing an important role in the inflammatory response and the remodelling process of ischemic myocardium in postoperative period.

Indexed as

Myocardial RevascularizationAnnexinsBiomarkersCell-Derived MicroparticlesCoronary Artery DiseaseCoronary VesselsEndothelial Progenitor CellsEndothelium, VascularFlow CytometryFollow-Up StudiesHumansPostoperative PeriodPrognosisProspective StudiesVasodilationAnnexinsANXA9 protein, humanBiomarkersBiomarkersCirculating microparticlesCoronary artery diseaseEndothelial progenitor cells

Identifiers

PMID28623398
OpenAlexW2626314135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.